AstraZeneca pilots diabetes drug as potential COVID-19 treatment
Britain's AstraZeneca is testing a diabetes drug as a potential treatment for COVID-19 patients who also had existing heart and kidney problems, its second trial of an approved therapy to help treat the disease caused by the coronavirus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Cardiology | Coronavirus | COVID-19 | Diabetes | Endocrinology | Health | Heart | UK Health | Urology & Nephrology